Pharmaceutical

Botulinum battle heats up with FDA approving Daxxify for cervical dystonia

Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to therapeutics.

Aug 14, 2023 - 20:00
Botulinum battle heats up with FDA approving Daxxify for cervical dystonia
Daxxify becomes the latest botulinum toxin to make the jump from aesthetics to therapeutics.
Read the original article

Tags:

Previous Article

STAT+: Pharma budget tightening trickles down to Doximity

Next Article

LifeArc invests nearly $10m in Crick Institute’s Africa Scheme

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Gene therapy offered this 7-year-old freedom. The price: a grueling year

Gene therapy offered this 7-year-old freedom. The price...

Dec 13, 2023

Allscripts Healthcare Solutions gets grant for optimizing patient overview in user interface for medical processing device

Allscripts Healthcare Solutions gets grant for optimizi...

Jun 8, 2024

Opinion: We finally have new Alzheimer’s drugs. How do we decide who gets them?

Opinion: We finally have new Alzheimer’s drugs. How do ...

Jul 8, 2023